A poster on our latest results on 4P004 entitled « Liraglutide Has Potent Anti-inflammatory And Anti-catabolic Activity In Two Cell Types Implicated In Osteoarthritis » (#435) will be presented during the OARSI Connect online event on 2021 April 29-May 1, by Pr. Francis Berenbaum (4Moving Biotech’s CEO/CMO, Head of Rheumatology department at Saint-Antoine Hospital, and Professor of Rheumatology at Sorbonne University, in Paris, France).

For further information, please click on the following image:

‍